Recombinant Erythropoietine (Rh-EPO) for Reduction of Perinatal Arterial Ischemic Stroke: A Safety and Feasibility Study"
- Benders, M. (Speaker)
Activity: Talk or presentation › Oral presentation › Academic
Activity: Talk or presentation › Oral presentation › Academic